US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Boston Scientific (NY:BSX)

42.60 -0.63 (-1.46%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Gapping S&P500 stocks in Thursday's session ↗
Via Chartmill
News headline image
Stock Market Today, May 27: Boston Scientific Plunges After Reiterating Underwhelming Full Year Growth Guidance ↗
Investors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today, May 27, 2026. 
Via The Motley Fool
Topics Stocks
Which S&P500 stocks are moving on Wednesday? ↗
Via Chartmill
News headline image
Boston Scientific Is Betting $1.5 Billion on a Massive Market -- and Wall Street Is Paying Attention ↗
The medical device giant just opened its wallet for a stake in a privately held company with a groundbreaking product. 
Via The Motley Fool
Boston Scientific Corp (NYSE:BSX) GARP Growth at a Reasonable Price Meets Strong Fundamentals ↗
Via Chartmill
Boston Scientific Corp (NYSE:BSX) Shines in Quality "Caviar Cruise" Screen ↗
Via Chartmill
Boston Scientific Corp (NYSE:BSX) Offers a Textbook Example of Affordable Growth ↗
Via Chartmill
These S&P500 stocks are the most active in today's session ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Gapping S&P500 stocks in Wednesday's session ↗
Via Chartmill
News headline image
Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing ↗
This biotech focuses on biologic therapies for immunological diseases, with lead candidates in nephrology and infectious disease. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch ↗
Biotech firm Nektar Therapeutics advances a pipeline of immunology and oncology candidates through research-driven collaborations. 
Via The Motley Fool
News headline image
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% ↗
GeneDx Holdings delivers AI-powered clinical and genomic data analysis for healthcare providers seeking precision medicine solutions. 
Via The Motley Fool
Topics Artificial Intelligence
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Which S&P500 stocks are moving before the opening bell on Monday? ↗
Via Chartmill
News headline image
2 Large-Cap Stocks to Consider Right Now and 1 We Turn Down
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit... 
Via StockStory
News headline image
3 Growth Stocks to Add to Your Roster
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil... 
Via StockStory
News headline image
BSX FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
3 Growth Stocks the Market Is Throwing Away and Why You Should Pick Them Up ↗
Don't let their current weakness deter you. Sometimes, investors collectively misread and misprice the situation. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
BSX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Deadline Soon: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
BOSTON SCIENTIFIC CORPORATION (BSX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
The 5 Most Interesting Analyst Questions From Boston Scientific’s Q1 Earnings Call
Boston Scientific’s first quarter saw a strong positive market reaction, underpinned by solid organic sales growth and improved operating margins. Management... 
Via StockStory
Topics Earnings
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX
From Pomerantz LLP
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de... 
Via StockStory
Top S&P500 movers in Friday's session ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
BOSTON SCIENTIFIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Boston Scientific Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces a Securities Class Action Lawsuit Filed Against Boston Scientific Corporation (BSX)
From Bernstein Liebhard LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >